Gene Query: IFT57

Dataset Description Geneva Score
Gene expression changes associated with resistance to tagraxofusp (SL-401) 67.38
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 48.31
RNA-seq analysis of AML cells in response to ASLAN003 38.93
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 38.01
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 38.01
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 37.72
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 33.57
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 33.57
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 31.42
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 31.17
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 31.17
Small-molecule targeting of brachyury transcription factor addiction in chordoma 24.95
Landscape of H3K4me3 in human CD19 cells 22.98
Role for citron kinase in prostate cancer growth 21.75
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 20.36
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 20.31
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 20.31
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 20.28
RNA-Seq from early time points in the kidney differentiation protocol 20.07
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 19.05
Transcriptomic analyssis following EHMT1/2 inhibition 18.89
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 18.88
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 18.31
MARS Seq data from human cortical organoids 17.36
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 17.09
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 17.09
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 16.64
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 16.64
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 16.58
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 16.28
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 15.62
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 15.05
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 14.23
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 14.18
Altering cancer transcriptomes using epigenomic inhibitors 14.18
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 14.17
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 13.91
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 13.72
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 13.17
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 13.14
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 13.12
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 12.93
Oncogenic MYC induces a dependency on the spliceosome in human cancer 12.16
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 11.89
SETBP1-WT and SETBP1-G870S epigenetic landscapes 11.86
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 11.86
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 11.72
CD74 role in transcription regulation [RNA-seq] 11.67
CD74 role in transcription regulation 11.67
FOXD3 is a novel tumor suppressor in lung cancer 11.34
RNA sequencing of matched nephrectomy samples [RNA-seq] 11.32
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 11.32
CircRNAome diversity in human mature B-cells, T-cells and monocytes 11.13
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 11.02
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 10.76
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 10.73
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 10.73
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 10.72
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 10.55
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 10.55
Tracking distinct RNA populations using efficient and reversible covalent chemistry 10.47
Transcriptome analysis of U87 cells upon LINC00152 knockdown 10.34
HNF1A deficiency impairs β-cell fate, granule maturation and function 10.22
Next generation sequencing of small RNAs isolated from exosomes in human semen 10.15
The Human Testis Cell Atlas via Single-cell RNA-seq 10.06
JAK dependent survival of ALK- ALCL 9.97
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 9.96
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 9.94
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 9.81
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 9.74
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 9.7
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 9.67
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 9.66
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 9.47
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 9.23
Identification of transcription start sites for human A549 cell line using ReCappable-seq 9.22
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 9.18
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 9.17
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 9.17
AR-independent prostate cancer is sustained through FGF signaling 9.07
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 9.06
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 8.96
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 8.95
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 8.95
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 8.89
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 8.84
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 8.83
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 8.83
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 8.8
Human cell line and subcutaneous tumor 8.75
ETV7 and interferon response 8.63
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 8.63
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 8.63
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 8.62
The cohesin complex prevents Myc-induced replication stress 8.55
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 8.48
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 8.46
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 8.46
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 8.43
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 8.35
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 8.32
Human cells contain natural double-stranded RNAs with potential regulatory capacity 8.26
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 8.21
Neonatal and adult human testis defined at the single-cell level 8.21
Reprogrammed myeloid cell transcriptomes in NSCLC 8.1
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 8.04
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 7.84
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 7.84
Characterization of human ILC2 subsets 7.71
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 7.67
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 7.66
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 7.66
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 7.61
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 7.61
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 7.54
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 7.48
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 7.45
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 7.43
Loss of CREBBP results in gene expression repression in lymphoma cells 7.4
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 7.4
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 7.38
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 7.37
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 7.31
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 7.31
Accurate annotation of human protein-coding small open reading frames 7.29
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 7.25
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 7.23
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 7.17
LNCaP treated with iBET 7.03
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 6.99
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 6.99
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 6.93
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 6.81
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 6.78
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 6.76
Mutational landscape of splicing genes and functional consequences across 33 cancer types 6.65
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 6.64
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 6.64
scRNASeq analysis of cycling cardiomyocytes 6.62
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 6.57
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 6.48
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 6.48
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 6.45
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 6.45
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 6.42
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 6.41
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 6.41
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 6.37
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 6.37
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 6.33
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 6.33
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 6.32
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 6.31
RNAseq analysis of ESRP regulated splicing events in prostate cancer 6.29
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 6.28
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 6.28
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 6.26
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 6.26
IDH3a KO RNA-seq 6.25
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 6.24
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 6.21
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 6.13
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 6.12
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 6.07
Gene expression changes after LOC550643 silencing 6.06
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 6.02
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 5.99
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 5.99
WRN knockout effects upon gene expression in SW48 and OVK18 5.95
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 5.94
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 5.9
MYC dependent mRNA translation shapes gene expression and cell biology 5.89
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 5.86
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 5.86
Bone marrow derived human B cells [normal proB] 5.78
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 5.78
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 5.69
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 5.64
Generating Patterned Kidney Organoids for Studying Development and Diseases 5.62
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 5.61
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 5.59
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 5.55
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 5.54
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 5.5
RNA-seq in transgenic cells 5.39
A novel target of EZH1/2 for treatment of mantle cell lymphoma 5.35
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 5.35
Gene expression profile of human iPSC-derived nephron progenitor cells 5.31
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 5.3
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 5.28
Identification of a LIF-responsive replication-competent human β cell 5.27
DART-seq: an antibody-free method for global m6A detection 5.27
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 5.24
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 5.22
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 5.21
RNA expression analysis upon JMJD1C depletion 5.21
A single cell reference map for human blood and tissue T cell activation 5.14
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 5.14
Overexpression and knockdown experiment for circCSNK1G3 5.05
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 5.03
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 5.03
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 5.01
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 5.01
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 4.98
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 4.98
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 4.98
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 4.97
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 4.92
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 4.92
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 4.92
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 4.88
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 4.88
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 4.88
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 4.88
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 4.88
SLIGRL-induced gene expression changes in NHEK cells 4.86
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 4.85
ARID1A regulates condensin II distribution and chromosomal partition 4.84
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 4.84
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 4.79
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 4.79
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 4.78
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 4.66
TCF7L1 knockdown in pancreatic cancer 4.65
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 4.63
mRNA differential expression analysis in a human ex vivo model of chronic wounds 4.61
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 4.58
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 4.55
An optimization system for isolating and sequencing of single human colon cancer cells 4.55
N6-methyladenine DNA Modification in Glioblastoma 4.54
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 4.54
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 4.51
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 4.47
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 4.39
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 4.39
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 4.35
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 4.35
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 4.32
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 4.31
R430: A potent inbibitor of DNA and RNA viruses 4.31
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 4.3
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 4.29
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 4.28
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 4.27
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 4.27
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 4.26
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 4.21
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 4.21
RNA sequencing analysis of human embryonic stem cells and axial progenitors 4.21
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 4.2
RNA-Seq from human ILC transitional populations 4.2
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 4.2
Gene Expression Profiling of WT and KDM3A Knocked out Cell 4.19
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 4.19
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 4.19
Global expression profiles in cardiac progenitor cells generated by ISX-9 4.19
PNET animal model: new insights (II) 4.18
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 4.18
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 4.17
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 4.17
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 4.16
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 4.08
RNA sequencing of human mammary epithelial cells 4.07
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 4.02
In vitro modeling of human germ cell development using pluripotent stem cells 4.01
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 3.9
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 3.88
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 3.88
Downregulation of DDX5/DDX17 and REST 3.87
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 3.82
HEK293 Heat-shock experiment 3.82
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 3.79
RNAseq of cell lines with knocked in ESR1 mutations 3.78
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 3.74
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 3.73
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 3.72
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 3.66
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 3.64
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 3.57
Regionally specified human pluripotent stem cell-derived astrocytes 3.56
Integrin signaling regulates YAP/TAZ to control skin homeostasis 3.56
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 3.55
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 3.55
Tpl-2 and MEK small molecule inhibitors 3.55
Tpl-2 small molecule project 3.55
Mapping interactions for the TNIP2 hub protein 3.5
TGF-β regulation of miRNA expression in pancreatic cancer 3.47
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 3.45
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 3.42
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 3.42
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 3.41
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 3.4
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 3.4
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 3.4
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 3.38
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 3.36
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 3.35
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 3.35
Expression profiling of etoposide-induced senescent cells 3.33
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 3.32
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 3.29
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 3.29
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 3.23
RNA-seq analysis of control and Myc-induced U2OS cells 3.21
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 3.21
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.21
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 3.2
Analysis of transcriptional regulation by Myt1 and Myt1l 3.2
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 3.2
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 3.11
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.09
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 3.08
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 3.07
TAF1 is critical for AE driven leukemogenesis 3.07
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 3.04
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 3.04
Gene expression activation in CLL mediated by MSCs contact 3.03
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 2.95
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 2.95
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.95
Transciptomic profiling of human fetal lung samples 2.93
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 2.92
Electronic cigarettes 2.92
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 2.9
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 2.87
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 2.83
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 2.83
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 2.83
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 2.81
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 2.81
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.79
BACH2 in human plasma cell fate decision 2.78
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 2.75
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 2.73
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 2.7
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 2.7
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 2.7
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 2.69
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 2.6
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 2.59
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 2.51
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 2.49
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 2.47
RNA-Seq in PWS iPSC-derived neurons 2.45
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 2.43
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 2.42
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 2.42
Primary Human B-cell Temporal Response to CD40L Stimulation 2.41
Fibroblasts in cholesteatoma activate osteoclasts. 2.41
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 2.39
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 2.39
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 2.39
Efficient derivation of microglia-like cells from human pluripotent stem cells 2.39
The role of CFTR in islet function 2.37
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 2.34
RNA-seq of SCLC PDX models treated with EP 2.33
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 2.32
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 2.31
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 2.29
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 2.26
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 2.24
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 2.24
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 2.2
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 2.17
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.15
Gene expression profiling of human and murine in vitro muscle differentiation 2.14
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.13
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 2.11
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 2.1
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 2.07
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 2.07
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 2.07
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 2.06
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 2.05
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 2.01
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 2.01
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 2.0
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.96
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 1.93
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.91
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 1.91
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.9
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 1.89
Measure transcript integrity using RNA-seq data 1.87
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.82
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 1.82
Global Mapping of Human RNA-RNA Interactions 1.78
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 1.78
m6A-dependent regulation of messenger RNA stability 1.76
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 1.76
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 1.75
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 1.75
Molecular analysis of renal cell carcinoma with unclassfied histology 1.75
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.74
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.74
Systematic discovery of endogenous human ribonucleoprotein complexes 1.73
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 1.72
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 1.69
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.66
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 1.65
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 1.65
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 1.64
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 1.6
MeRIP-seq for heat shock in B-cell lymphoma cells 1.58
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 1.57
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 1.54
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.53
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.53
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 1.46
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 1.42
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 1.42
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 1.42
Transcriptome analysis of human lung epithelial cells 1.42
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 1.42
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 1.4
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 1.39
RNA sequencing analysis of selumetinib-resistant CRC cells lines 1.34
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 1.34
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 1.34
Transcription elongation regulates genome 3D structure 1.3
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.26
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 1.24
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 1.22
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 1.22
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.21
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.19
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.19
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 1.18
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 1.08
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 1.08
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 1.04
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.0
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.95
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.95
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.91
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.83
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 0.83
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 0.82
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.82
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 0.76
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.76
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 0.75
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.74
Zika virus directly infects human peripheral neurons and induces cell death 0.73
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 0.72
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.68
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.67
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.66
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.65
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.64
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 0.63
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.61
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.61
Comparative Analysis of Cas9 Activators Across Multiple Species 0.61
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 0.56
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 0.56
Direct Isolation and Characterization of Human Nephron Progenitors. 0.51
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.47
Effect of nuclear IL-33 on gene expression 0.47
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.47
ML29755 RNA-seq data 0.46
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.46
Modulation of nonsense-mediated decay by rapamycin 0.45
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.45
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 0.45
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 0.44
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.43
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.41
Aging-associated patterns in the expression of human endogenous retroviruses 0.39
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.38
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.38
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.38
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.36
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.36
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.35
siRNA-mediated knockdown 0.35
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 0.35
Effect of BB608 on Gene Expression in HNSCC Cell Line 0.35
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 0.34
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 0.34
Transcriptome analysis reveals differential splicing events in IPF lung tissue 0.34
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 0.31
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.3
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 0.29
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 0.29
RNA-seq data 0.27
Transcriptional changes in lymphoma cells induced by LSD1 depletion 0.27
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 0.27
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.21
hNSCs siRNA NOVA2 0.16
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.15
Transcriptomic analysis of human tonsillar TFH subsets 0.12
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.12
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.11
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.09
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 0.07
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.06
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.04
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.02
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation